Issue link: http://digitaleditions.uberflip.com/i/1388210
152 Standalone Chapters 2020 | NMH Annual Rep t BIOCHEMISTRY The Biochemistry department provides an extensive range of Biochemistry, Endocrinology and specialised fetal monitoring for both the NMH and other hospitals. Clinical Activity The Endocrinology service continues to expand with increased in thyroid function testing and support for the diabetes clinics. The Introduction of Urinary Protein Creatinine ration testing has made a significant contribution to the assessment of proteinuria. The verification and introduction of PlGF and sFLT will permit better monitoring and triage of patients with pre-eclampsia Successes and Achievements 2020 • Verification and introduction of new immunoassay analyser permitting improved turnaround times and increase in test repertoire. • Introduction of Protein Creatinine Ratio • Verification and introduction of new Gem Blood Gas Analysers • Verification of Anti Sars CoV-2 antibody test • Verification of PlGG and sFLT Plans for 2021 • Transfer of 1 st trimester biochemistry to new platform • Verification and introduction of Point of Care Glucose meters across the hospital • Verification and introduction of indices to standardise reporting of lipaemic and haemolysed specimens • Prepare tender for replacement of chemistry analyser • Standardise point of care testing and governance • Seek a solution to offer HbA1c 'in house' to improve patient care for diabetics BLOOD TRANSFUSION Investigation of Blood Group and Antibodies. Provision of Blood and Blood Products. Supporting the prevention and management of Haemolytic Disease of the Fetus and the Newborn through detection and monitoring of antibodies, provision of routine Antenatal Anti D prophylaxis. Clinical Activity The introduction of the cell free DNA testing to establish fetal RhD status has led to a significant reduction in the administration of antenatal prophylactic Anti D both for potentially sensitising events and for the routine prophylaxis at 28 weeks.